Paper39201414
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
Jannati S and 2 others. Int J Mol Sci, 2024. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling. Papers, record 39201414. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201414
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammation | Major topic |
| Anticoagulants | Major topic |
| Receptors, Proteinase-Activated | Major topic |
| Signal Transduction | Major topic |
| Humans | |
| Administration, Oral | |
| Animals | |
| Rivaroxaban | |
| Pyridones |
Source PubMed
References304
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36769872 | Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. | J Clin Med | 2023 | https://conductscience.org/library/papers/36769872 | PubMed |
| 2 | 34639073 | Molecular Mechanism of the Anti-Inflammatory Action of Heparin. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639073 | PubMed |
| 3 | 15748242 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor. | J Thromb Haemost | 2005 | https://conductscience.org/library/papers/15748242 | PubMed |
| 4 | 24449213 | Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. | Blood | 2014 | https://conductscience.org/library/papers/24449213 | PubMed |
| 5 | 27476789 | Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. | Lancet Haematol | 2016 | https://conductscience.org/library/papers/27476789 | PubMed |
| 6 | 22262775 | Asthma and coagulation. | Blood | 2012 | https://conductscience.org/library/papers/22262775 | PubMed |
| 7 | 25573421 | Effects of age and sex on the single-dose pharmacokinetics and pharmacodynamics of apixaban. | Clin Pharmacokinet | 2015 | https://conductscience.org/library/papers/25573421 | PubMed |
| 8 | 28798139 | Impact of Non-Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28798139 | PubMed |
| 9 | 26749408 | Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa. | Am J Cardiovasc Drugs | 2016 | https://conductscience.org/library/papers/26749408 | PubMed |
| 10 | 30431565 | Comparison of dabigatran and warfarin used in patients with non-valvular atrial fibrillation: Meta-analysis of random control trial. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30431565 | PubMed |
| 11 | 36927031 | Evolutionary-scale prediction of atomic-level protein structure with a language model. | Science | 2023 | https://conductscience.org/library/papers/36927031 | PubMed |
| 12 | 24810388 | Edoxaban: a focused review of its clinical pharmacology. | Eur Heart J | 2014 | https://conductscience.org/library/papers/24810388 | PubMed |
| 13 | 32793635 | Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/32793635 | PubMed |
| 14 | 32244492 | A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32244492 | PubMed |
| 15 | 12176812 | Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts. | Ann Rheum Dis | 2002 | https://conductscience.org/library/papers/12176812 | PubMed |
| 16 | 17205215 | Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. | Clin Rheumatol | 2007 | https://conductscience.org/library/papers/17205215 | PubMed |
| 17 | 37980924 | Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial. | Lancet Haematol | 2024 | https://conductscience.org/library/papers/37980924 | PubMed |
| 18 | 29269019 | Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury. | Eur J Pharmacol | 2018 | https://conductscience.org/library/papers/29269019 | PubMed |
| 19 | 22849826 | Activation of PAR(2) receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22849826 | PubMed |
| 20 | 33204010 | Author Correction: Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction. | Sci Rep | 2020 | https://conductscience.org/library/papers/33204010 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42741326 | Rivaroxaban suppresses factor Xa-Driven PAR-2-ERK inflammatory, catabolic, osteoclastogenic, and mitochondrial dysfunction signaling in osteoarthritis-relevant chondrocytes: a drug-repurposing strategy for joint inflammation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42741326 | PubMed |
| 42737430 | Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737430 | PubMed |
| 42652063 | Physiological Lipid Palmitoylcarnitine Constrains Factor Xa Signalling Through PAR-2 to Attenuate ERK-Driven Inflammation and Preserve Mitochondrial Membrane Potential in Chondrocytes. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652063 | PubMed |
| 42625919 | Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care. | Front Neurol | 2026 | https://conductscience.org/library/papers/42625919 | PubMed |
| 42529014 | Rivaroxaban plus antiplatelet therapy for coronary artery ectasia: 36-month outcomes and risk prediction from a retrospective cohort study. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42529014 | PubMed |
| 42522843 | Engineering Host-Guest Interactions for Next-Generation Heparin Biosensors. | Small | 2026 | https://conductscience.org/library/papers/42522843 | PubMed |
| 42328643 | Real-world bleeding risk and molecular interaction profiles of direct oral anticoagulants: a comparative study integrating clinical outcomes and in silico docking. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42328643 | PubMed |
| 42105000 | Fondaparinux attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and inflammatory signaling via the TLR4/NLRP3 and NF-κB/IL-1β/MCP-1 pathways. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42105000 | PubMed |
| 42022786 | Biochemical Alterations Related to Vascular Injury in Smokers: Evidence from Nitric Oxide, Malondialdehyde, Nicotinic Acetylcholine Receptors, and Cotinine. | Vasc Health Risk Manag | 2026 | https://conductscience.org/library/papers/42022786 | PubMed |
| 41721545 | Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. | Cardiovasc Res | 2026 | https://conductscience.org/library/papers/41721545 | PubMed |
| 41262558 | Advances in Transdermal Drug Delivery Systems for Antithrombotic Therapy: A Systematic Review. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/41262558 | PubMed |
| 41002416 | Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells. | Cells | 2025 | https://conductscience.org/library/papers/41002416 | PubMed |
| 40943351 | Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943351 | PubMed |
| 40699690 | The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699690 | PubMed |
| 40648975 | Evaluation of CHA2DS2-VA Score and Systemic Inflammatory Indexes in Patients with Nonvalvular Atrial Fibrillation: A Case-Control Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40648975 | PubMed |
| 40564985 | Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40564985 | PubMed |
| 40457264 | KCNK2-mediated regulation of MMP-2/9 by PlGF influences uterine artery function in pregnancy-induced hypertension. | BMC Pregnancy Childbirth | 2025 | https://conductscience.org/library/papers/40457264 | PubMed |
| 40430925 | Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430925 | PubMed |
| 40353064 | Lower CALLY index levels indicate higher poor functional outcome risk in acute ischemic stroke patients treated with endovascular thrombectomy. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/40353064 | PubMed |
| 40243559 | Selective Modulation of PAR-2-Driven Inflammatory Pathways by Oleocanthal: Attenuation of TNF-α and Calcium Dysregulation in Colorectal Cancer Models. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243559 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201414
GET https://conductscience.org/api/papers/v1/39201414/references?page=2